Liu S - Search Results

1

Ubenimex, an APN inhibitor, could serve as an anti‑tumor drug in RT112 and 5637 cells by operating in an Akt‑associated manner.

Wang X, Liu Y, Liu W, Zhang Y, Guo F, Zhang L, Cui M, Liu S, Wu R. Wang X, et al. Among authors: liu y, liu s, liu w. Mol Med Rep. 2018 Mar;17(3):4531-4539. doi: 10.3892/mmr.2018.8402. Epub 2018 Jan 9. Mol Med Rep. 2018. PMID: 29328441 Free PMC article.

2

Ubenimex inhibits cell proliferation, migration and invasion in renal cell carcinoma: the effect is autophagy-associated.

Liu S, Xie F, Wang H, Liu Z, Liu X, Sun L, Niu Z. Liu S, et al. Among authors: liu z, liu x. Oncol Rep. 2015 Mar;33(3):1372-80. doi: 10.3892/or.2014.3693. Epub 2014 Dec 23. Oncol Rep. 2015. PMID: 25571917

3

Nephroblastoma overexpressed gene (NOV) enhances RCC cell motility through upregulation of ICAM-1 and COX-2 expression via Akt pathway.

Liu S, Han L, Wang X, Liu Z, Ding S, Lu J, Bi D, Mei Y, Niu Z. Liu S, et al. Among authors: liu z. Int J Clin Exp Pathol. 2015 Feb 1;8(2):1302-11. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 25973014 Free PMC article.

4

A Potent Chemotherapeutic Strategy with Eg5 Inhibitor against Gemcitabine Resistant Bladder Cancer.

Sun L, Lu J, Niu Z, Ding K, Bi D, Liu S, Li J, Wu F, Zhang H, Zhao Z, Ding S. Sun L, et al. Among authors: liu s. PLoS One. 2015 Dec 10;10(12):e0144484. doi: 10.1371/journal.pone.0144484. eCollection 2015. PLoS One. 2015. PMID: 26658059 Free PMC article.

5

Prognostic significance of two lipid metabolism enzymes, HADHA and ACAT2, in clear cell renal cell carcinoma.

Zhao Z, Lu J, Han L, Wang X, Man Q, Liu S. Zhao Z, et al. Among authors: liu s. Tumour Biol. 2016 Jun;37(6):8121-30. doi: 10.1007/s13277-015-4720-4. Epub 2015 Dec 29. Tumour Biol. 2016. PMID: 26715271

6

Ubenimex inhibits cell proliferation, migration and invasion by inhibiting the expression of APN and inducing autophagic cell death in prostate cancer cells.

Wang X, Niu Z, Jia Y, Cui M, Han L, Zhang Y, Liu Z, Bi D, Liu S. Wang X, et al. Among authors: liu z, liu s. Oncol Rep. 2016 Apr;35(4):2121-30. doi: 10.3892/or.2016.4611. Epub 2016 Feb 3. Oncol Rep. 2016. PMID: 26846372

7

CYLD downregulates Livin and synergistically improves gemcitabine chemosensitivity and decreases migratory/invasive potential in bladder cancer: the effect is autophagy-associated.

Yin L, Liu S, Li C, Ding S, Bi D, Niu Z, Han L, Li W, Gao D, Liu Z, Lu J. Yin L, et al. Among authors: liu z, liu s. Tumour Biol. 2016 Sep;37(9):12731-12742. doi: 10.1007/s13277-016-5157-0. Epub 2016 Jul 22. Tumour Biol. 2016. PMID: 27448305

8

Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells.

Wang Z, Liu S, Ding K, Ding S, Li C, Lu J, Gao D, Zhang T, Bi D. Wang Z, et al. Among authors: liu s. Tumour Biol. 2016 Nov;37(11):15133-15143. doi: 10.1007/s13277-016-5395-1. Epub 2016 Sep 27. Tumour Biol. 2016. PMID: 27677286

9

Ubenimex attenuates acquired sorafenib resistance in renal cell carcinoma by inhibiting Akt signaling in a lipophagy associated mechanism.

Liu S, Gao M, Wang X, Ding S, Lv J, Gao D, Wang Z, Niu Z. Liu S, et al. Oncotarget. 2016 Nov 29;7(48):79141-79153. doi: 10.18632/oncotarget.13003. Oncotarget. 2016. PMID: 27816967 Free PMC article.

10

Ubenimex enhances the radiosensitivity of renal cell carcinoma cells by inducing autophagic cell death.

Liu S, Wang X, Lu J, Han L, Zhang Y, Liu Z, Ding S, Liu Z, Bi D, Niu Z. Liu S, et al. Among authors: liu z. Oncol Lett. 2016 Nov;12(5):3403-3410. doi: 10.3892/ol.2016.5036. Epub 2016 Aug 22. Oncol Lett. 2016. PMID: 27900012 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78,129 results

Search Page

Filters